REPL (STOCKS)
Replimune Group, Inc.
$7.944400
+0.184400 (+2.38%)
Prev close: $7.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sushil Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $658.10M
- Employees
- 479
- P/E (TTM)
- -2.23
- P/B (TTM)
- 2.94
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q3)
|
$-0.77 | $-0.91 | +0.1378 | +15.18% |
|
Sep 2025 (Q2)
|
$-0.90 | $-0.80 | -0.0987 | -12.32% |
|
Jun 2025 (Q1)
|
$-0.95 | $-0.82 | -0.1266 | -15.38% |
|
Mar 2025 (Q4)
|
$-0.82 | $-0.77 | -0.0523 | -6.81% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $10.64M |
| Operating Expenses | $325.91M |
| Research and Development | $222.84M |
| Other Operating Expenses | $103.07M |
| Operating Income/Loss | -$325.91M |
| Income/Loss From Continuing Operations After Tax | -$314.39M |
| Income/Loss From Continuing Operations Before Tax | -$315.27M |
| Income Tax Expense/Benefit | -$418.00K |
| Net Income/Loss | -$314.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$314.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$314.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.44 |
| Diluted Earnings Per Share | -$3.44 |
| Basic Average Shares | 95,324,933 |
| Diluted Average Shares | 95,324,933 |
| Assets | $333.59M |
| Current Assets | $280.35M |
| Noncurrent Assets | $53.24M |
| Fixed Assets | $13.85M |
| Other Non-current Assets | $39.39M |
| Liabilities | $123.05M |
| Current Liabilities | $50.09M |
| Accounts Payable | $5.65M |
| Other Current Liabilities | $44.44M |
| Noncurrent Liabilities | $72.96M |
| Equity | $210.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $210.54M |
| Liabilities And Equity | $333.59M |
| Net Cash Flow From Operating Activities | -$277.91M |
| Net Cash Flow From Operating Activities, Continuing | -$277.91M |
| Net Cash Flow From Investing Activities | $216.64M |
| Net Cash Flow From Investing Activities, Continuing | $216.64M |
| Net Cash Flow From Financing Activities | $10.49M |
| Net Cash Flow From Financing Activities, Continuing | $10.49M |
| Exchange Gains/Losses | $1.50M |
| Net Cash Flow | -$49.29M |
| Net Cash Flow, Continuing | -$50.79M |
| Comprehensive Income/Loss | -$315.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$315.45M |
| Other Comprehensive Income/Loss | -$71.20M |